share_log

Clover Health | 10-Q: Q2 2024 Earnings Report

Clover Health | 10-Q: Q2 2024 Earnings Report

Clover Health | 10-Q：2024財年二季報
美股SEC公告 ·  08/08 20:09

Moomoo AI 已提取核心訊息

Clover Health announced its Q2 2024 financial results, reporting total revenue of $356.3 million, up 11.3% year-over-year. The company achieved net income of $7.4 million, a significant improvement from a net loss of $28.8 million in Q2 2023. Premiums earned increased by 11.3% to $349.9 million, driven by higher risk adjustment revenue and member retention efforts.Net medical claims incurred rose slightly by 1.7% to $248.3 million. The company's medical care ratio improved to 74.8% from 81.9% in the prior year period. Clover Health ended the quarter with 80,261 Medicare Advantage members. The company also reported a strong liquidity position with $482.8 million in cash, cash equivalents, and investments as of June 30, 2024.Clover Health launched Counterpart Health, Inc., a new SaaS and tech-enabled services solution, aiming to extend its AI-powered care management platform to other Medicare Advantage payors and providers. The company also announced its exit from the ACO REACH program for the 2024 performance year, focusing on its core Medicare Advantage business. Management expressed confidence in the company's financial position and growth strategies for the coming year.
Clover Health announced its Q2 2024 financial results, reporting total revenue of $356.3 million, up 11.3% year-over-year. The company achieved net income of $7.4 million, a significant improvement from a net loss of $28.8 million in Q2 2023. Premiums earned increased by 11.3% to $349.9 million, driven by higher risk adjustment revenue and member retention efforts.Net medical claims incurred rose slightly by 1.7% to $248.3 million. The company's medical care ratio improved to 74.8% from 81.9% in the prior year period. Clover Health ended the quarter with 80,261 Medicare Advantage members. The company also reported a strong liquidity position with $482.8 million in cash, cash equivalents, and investments as of June 30, 2024.Clover Health launched Counterpart Health, Inc., a new SaaS and tech-enabled services solution, aiming to extend its AI-powered care management platform to other Medicare Advantage payors and providers. The company also announced its exit from the ACO REACH program for the 2024 performance year, focusing on its core Medicare Advantage business. Management expressed confidence in the company's financial position and growth strategies for the coming year.
Clover Health公佈了2024年第二季度財務結果，報告總營業收入爲35630萬，同比增長11.3%。公司實現了740萬的凈利潤，相比2023年第二季度的2880萬淨虧損有了顯著改善。由於風險調整收入的增加和會員留存的努力，所賺取的保費增加了11.3%，達到了34990萬。淨醫療索賠略微上漲1.7%，達到24830萬。公司的醫療保健比例從上年同期的81.9%改善至74.8%。Clover Health在本季度末擁有80261名醫療保險優勢會員。截止到2024年6月30日，公司還報告了強勁的流動性，現金、現金等價物和投資總額爲48280萬。Clover Health推出了Counterp...展開全部
Clover Health公佈了2024年第二季度財務結果，報告總營業收入爲35630萬，同比增長11.3%。公司實現了740萬的凈利潤，相比2023年第二季度的2880萬淨虧損有了顯著改善。由於風險調整收入的增加和會員留存的努力，所賺取的保費增加了11.3%，達到了34990萬。淨醫療索賠略微上漲1.7%，達到24830萬。公司的醫療保健比例從上年同期的81.9%改善至74.8%。Clover Health在本季度末擁有80261名醫療保險優勢會員。截止到2024年6月30日，公司還報告了強勁的流動性，現金、現金等價物和投資總額爲48280萬。Clover Health推出了Counterpart Health, Inc.，這是一個新的Saas-雲計算和技術支持的服務解決方案，旨在將其人工智能驅動的護理管理平台擴展到其他醫療保險優勢支付方和提供者。公司還宣佈退出2024表現年的ACO REACH項目，專注於其核心的醫療保險優勢業務。管理層對公司未來一年的財務狀況和增長策略表示信懇智能。

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

獨立文件4  查看翻譯

獨立文件5  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間